The National Academy of Medicine

The National Academies provide expert advice to the U.S. government on issues of science, health, and engineering and, today, comprise three private, nonprofit institutions: The National Academy of Sciences (NAS), National Academy of Engineering (NAE), and National Academy of Medicine (NAM). The NAM is the newest of these, established in 1970 originally under the name Institute of Medicine (IOM).

Membership to the Academies is considered one of the highest honors bestowed to a U.S. scientist. Below is a list of the many IRP scientists, past and present, elected to the NAM. Click to view our list of NAS members and NAE members.

IRP scientists elected to the NAM (year of election):

  • Stephen J. Chanock (2024). For being an international leader in cancer genetics, identifying susceptibility alleles in more than a dozen cancers. He has awards for first describing clonal mosaicism and its relationship to cancer and aging. He has created and fostered international consortia on BRCA genetics and COVID-19.
  • Lindsey A. Criswell (2024). For defining genetic and epigenetic contributions to development of autoimmune rheumatic disorders and their relationship to specific serologic and clinical phenotypes and to genetic ancestry of patients. Her work has transformed understanding of the pathogenesis of lupus, rheumatoid arthritis, Sjögren’s disease, and related diseases.
  • Niki Moutsopoulos (2024). For making seminal contributions towards understanding and treating the prevalent human oral disease periodontitis. Her laboratory has contributed to the understanding of both homeostatic and pathogenic inflammation in the oral cavity, informing interventions for both rare and common forms of aggressive forms of periodontal disease.
  • Avindra Nath (2024). For pioneering research and strong leadership in emerging and persistent infections of the nervous system by studying pathophysiology, developing treatments, and conducting clinical studies. This includes retroviruses, Ebola, Zika, nodding syndrome, and COVID-19 as well as Long COVID, ME/CFS, and Gulf War syndrome.
  • Nina Schor (2024). For pioneering research that has radically improved outcomes for children with tumors of the nervous system. She has been a role model, mentor, and beacon to countless other female physician-scientists throughout her amazing career, from bench scientist to academic dean to NIH leader.
  • Michael F. Chiang (2023). For pioneering applications of biomedical informatics to ophthalmology in artificial intelligence, telehealth, pediatric retinal disease, electronic health records, and data science, including methodological and diagnostic advances in AI for pediatric retinopathy of prematurity, and for contributions to developing and implementing the largest ambulatory care registry in the United States. 
  • Eric Green (2023). For leading the development of technologies and tools for translating genomics to clinical practice. Globally, he has pioneered cooperation to advance genomic fluency and precision medicine. In parallel, he has modeled diversity and inclusion in NHGRI senior leadership and workforce training programs. 
  • Eugene V. Koonin (2022). For his work on the identification of clusters of homologous genes that created the foundation for systematic study of genome evolution and function; his work illuminated the evolution of microbes and viruses including discovery of adaptive immunity in bacteria and archaea, the basis for the genome editing technology known as CRISPR.
  • Bruce J. Tromberg (2022). For his leadership in biomedical engineering and the NIH Rapid Acceleration of Diagnostics Technology (RADx Tech) initiative. 
  • Jennifer Webster-Cyriaque (2022). For making seminal contributions to our understanding of the role of virus-host interaction in oral disease. 
  • Carolina Barillas-Mury (2021). For discovering how plasmodium parasites manipulate the mosquito immune system to survive, and how these interactions maintain global malaria transmission.
  • Mariana Kaplan (2021). For seminal contributions that have significantly advanced the understanding of the pathogenic role of the innate immune system in systemic autoimmune diseases, atherosclerosis, and immune-mediated vasculopathies.
  • Shannon Zenk (2021). For research on the built environment in racial/ethnic minority and low-income neighborhoods that enriched understanding of the factors that influence health and contribute to health disparities, demonstrating the need for multilevel approaches to improve health and achieve health equity.
  • Peter L. Choyke (2020). For pioneering advances in the imaging of prostate cancer that have enabled accurate localization of clinically significant tumors. His work has allowed more accurate and efficient biopsies as well as focal therapies that cause fewer side effects than conventional therapies.
  • Cynthia E. Dunbar (2020). For leading pioneering genetic marking and therapy trials targeting hematopoietic stem cells, and developing uniquely predictive non-human primate models to successfully improve the safety and efficiency of various gene therapies as well as gain insights into hematopoiesis and immunology.
  • Heinz Feldmann (2020). For leading the development of the vesicular stomatitis virus-based vaccine platform that resulted in the first Ebola vaccine. His mobile diagnostic laboratory for public health and biodefense emergencies is now used by the World Health Organization.
  • Louis M. Staudt (2020). For demonstrating that genetic profiling can distinguish lymphoma subtypes, predict patient survival, and individualize therapy, thus playing a key role in launching the era of cancer precision medicine. He devised loss-of-function genetic screens for essential cancer genes, thereby enabling effective targeted therapies for molecular subtypes of lymphoma.
  • Carlos Alberto Zarate Jr. (2020). For demonstrating that a single ketamine infusion has rapid, robust, and relatively sustained antidepressant effects in individuals with treatment-resistant depression and bipolar depression, in addition to significant anti-suicidal and anti-anhedonic effects. Identifying ketamine as a rapid-acting antidepressant and anti-suicidal ideation agent was a paradigm shift in psychiatry.
  • Michael Lenardo (2019). For the discoveries of molecular mechanisms of immunological tolerance, seminal work on programmed cell death, defining new inherited genetic diseases of immunity, and developing targeted therapies that have saved the lives of children suffering from certain of these devastating diseases.
  • Luigi D. Notarangelo (2019). For making seminal discoveries in the characterization of the molecular and cellular bases of several forms of primary immune deficiencies, and for his leadership role in the creation of networks of centers that care for patients with these disorders, aiming to improve diagnosis and treatment.
  • Andre Nussenzweig (2019). For making seminal discoveries that speak to how cells maintain their own genome stability, allow chromosome fragility, and license leukemogenesis at the hands of aberrant DNA repair.
  • Julie Segre (2019). For pioneering whole-genome sequencing to track the transmission of fully antibiotic resistant Gram-negative bacterium in the midst of a deadly hospital outbreak.
  • William Gahl (2018). For contributions that include creating the Undiagnosed Diseases Program within intramural NIH to meld individualized patient care with next-generation sequencing and to provide insights into new mechanisms of disease; spearheading expansion to the national Undiagnosed Diseases Network and the Undiagnosed Disease Network International; and championing the sharing of genetic databases and best practices.
  • Steve Holland (2018). For distinguished achievements in primary immunodeficiencies and infectious diseases, including the recognition, treatment, genomic identification, and cure of previously unexplained diseases as well as the identification and characterization of novel pathogens in those diseases.
  • Ellen Leibenluft (2018). For highlighting the need to carefully evaluate children who may have bipolar disorder; identifying chronic irritability, a new clinical problem which differs from pediatric bipolar disorder; and pioneering the use of cognitive neuroscience to address fundamental clinical questions on nosology and treatment of pediatric mental disorders.
  • Charles Rotimi (2018). For groundbreaking research in African and African ancestry populations, providing new insights into the genetic and environmental contributors to a variety of important clinical conditions, as well as health disparities locally and globally.
  • Christine Grady (2017)
  • George F. Koob (2017)
  • Karen Berman (2016)
  • Leslie G. Biesecker (2016)
  • T. Jake Liang (2016)
  • Christopher Austin (2015)
  • Walter Koroshetz (2015)
  • John J. O’Shea (2014)
  • Diana W. Bianchi (2013)
  • Ronald Germain (2013)
  • Warren Leonard (2013)
  • Daniel Pine (2013)
  • Dan Kastner (2012)
  • Linda Birnbaum (2010)
  • Ira Pastan (2010)
  • Thomas Wellems (2010)
  • Carl Wu (2010)
  • Story Landis (2009)
  • Griffin Rodgers (2009)
  • Elaine Jaffe (2008)
  • Marston Linehan (2008)
  • Bruce Baum (2007)
  • Leighton Chan (2007)
  • Gary H. Gibbons (2007)
  • Roberto Romero (2007)
  • H. Clifford Lane (2006)
  • Alan DeCherney (2004)
  • Thomas Quinn (2004)
  • Roger Glass (2003)
  • Michael Gottesman (2003)
  • Douglas Lowy (2003)
  • Lawrence Tabak (2002)
  • Kathryn Zoon (2002)
  • Eliseo Perez-Stable (2001)
  • Nora Volkow (2000)
  • Richard Hodes (1999)
  • Johanna T. Dwyer (1998)
  • Robert Wurtz (1997)
  • Mitchell Gail (1996)
  • Vivian Pinn (1995)
  • Clement J. McDonald (1994)
  • Judith Rapoport (1993)
  • Joseph Fraumeni (1992)
  • Francis Collins (1991)
  • Louis Miller (1991)
  • Steven Rosenberg (1987)
  • Samuel A. Wells, Jr. (1987)

Partial list of former IRP scientists elected to the IOM/NAM (alphabetical):

  • Harvey Alter (2002)
  • Julius Axelrod (1980)
  • Yasmine Belkaid (2018)
  • Jeremy Berg (2010)
  • Antonello Bonci (2016)
  • Roscoe O. Brady (1985)
  • Patricia Flatley Brennan (2001)
  • Samuel Broder (1993)
  • Dennis Charney (2000)
  • George Chrousos (2010)
  • Ezekiel Emmanuel (2004)
  • Anthony Fauci (1987)
  • Kenneth Fischbeck (1999)
  • Donald Fredrickson (1971)
  • Maria Freire (2008)
  • Jennifer Lippincott-Schwartz (2009)
  • Naomi Lynn Gerber (2008)
  • John Gallin (1996)
  • Jessica Gill (2021)
  • Harold Ginsberg (1981)
  • Frederick Goodwin (1985)
  • Enoch Gordis (1988)
  • Joshua Gordon (2018)
  • Patricia Grady (1999)
  • Alan Guttmacher (2004)
  • Florence Haseltine (1993)
  • Betsy Humphreys (1999)
  • Thomas Insel (2003)
  • Robert Kaplan (2005)
  • Stephen Katz (1992)
  • Ruth Kirschstein (1983)
  • Claude Klee (1992)
  • Richard Krause (1981)
  • Carl Kupfer (1983)
  • Philip Leder (1979)
  • Donald Lindberg (1985)
  • David Lipman (2000)
  • Crystal L. Mackall (2022)
  • Husseini Manji (2008)
  • John R. Mascola (2017)
  • Donald Mattison (2000)
  • Mortimer Mishkin (1990)
  • Gary Nabel (1998)
  • John Niederhuber (2008)
  • Marshall Nirenberg (1971)
  • James M. Ostell (2007)
  • William Paul (1990)
  • Roderic I. Pettigrew (NAM 2007 and NAE 2010)
  • Alan Rabson (1987)
  • Matilda White Riley (1979)
  • John Robbins (1993)
  • John Seal (1984)
  • Norman E. Sharpless (2022)
  • Paul Sieving (2006)
  • Louis Sokoloff (1997)
  • Leslie Ungerleider (2001)
  • Hannah A. Valantine (2020)
  • Harold Varmus (1991)
  • Thomas Waldmann (1992)
  • Daniel Weinberger (1999)
  • Flossie Wong-Staal (1994)

Continue Exploring the IRP

This page was last updated on Friday, December 13, 2024